Hematuria ultrasound: Difference between revisions

Jump to navigation Jump to search
Line 11: Line 11:
* Detecting renal parenchymal lesions (e.g. renal cell carcinoma)
* Detecting renal parenchymal lesions (e.g. renal cell carcinoma)
* For characterizing renal cysts Showing renal calculi
* For characterizing renal cysts Showing renal calculi
For determining ureteric obstruction (Hydronephrosis)
* For determining ureteric obstruction (Hydronephrosis)
'''Disadvantages'''
'''Disadvantages:'''
US is poor at detecting small lesions within the collecting system (e.g. urothelial cell carcinoma (UCC) of the renal pelvis)
* US is poor at detecting small lesions within the collecting system (e.g. urothelial cell carcinoma (UCC) of the renal pelvis)


==References==
==References==

Revision as of 05:08, 30 January 2017

Hematuria Microchapters

Home

Patient Information

Overview

Definition

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hematuria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hematuria ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hematuria ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hematuria ultrasound

CDC on Hematuria ultrasound

Hematuria ultrasound in the news

Blogs on Hematuria ultrasound

Directions to Hospitals Treating Hematuria

Risk calculators and risk factors for Hematuria ultrasound

Steven C. Campbell, M.D., Ph.D.;Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]

Overview

Ultrasound(US) offers an accurate, noninvasive approach to rule out obstructive uropathy, determine renal size and cortical thickness, and look for masses or cysts. The availability of color duplex to assess renal vascular flow and resistance provides additional information regarding renal parenchyma. US is the first choice among the imaging studies to evaluate a patient with deterioration in renal function, because it does not involve the usage of nephrotoxic contrast media. US is the imaging test to consider in patients with suspected glomerular hematuria, as manifested by dysmorphic RBCs, proteinuria of at least 2+, and RBC casts. Because radiation is not involved, US is safe in pregnant patients as well. It is less accurate in detecting ureteral lesions such as nonobstructing stones, and thus may not be the first choice for evaluating a suspected urological cause of hematuria.[1]

Ultrasound

Advantages

  • Ultrasound of the abdomen and pelvis is safe.[2][3]
  • It is good at detecting
  • Detecting renal parenchymal lesions (e.g. renal cell carcinoma)
  • For characterizing renal cysts Showing renal calculi
  • For determining ureteric obstruction (Hydronephrosis)

Disadvantages:

  • US is poor at detecting small lesions within the collecting system (e.g. urothelial cell carcinoma (UCC) of the renal pelvis)

References

  1. Rew, Karl (2010). Primary care urology. Philadelphia, Pa. London: Saunders. ISBN 978-1437724899.
  2. "www.surgeryjournal.co.uk".
  3. Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ et al. (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188 (6 Suppl):2473-81. DOI:10.1016/j.juro.2012.09.078 PMID: 23098784

Template:WH Template:WS